Is the mTOR-signalling cascade disrupted in Schizophrenia?

Journal of Neurochemistry

Volumn 129, Issue 3, 2014, Pages 377-387

  Gururajan, Anand ^a   Van Den Buuse, Maarten ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

BDNF; glutamate; mammalian target of rapamycin; Reelin; schizophrenia

Indexed keywords

BDNF; GLUTAMATE; MAMMALIAN TARGET OF RAPAMYCIN; REELIN; SCHIZOPHRENIA;

ANIMALS; HUMANS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84898949603     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12622     Document Type: Review

References (99)

1. Abi-Dargham A., Laruelle M., Aghajanian G. K., Charney D., and, Krystal J., (1997) The role of serotonin in the pathophysiology and treatment of schizophrenia. J. Neuropsychiatry Clin. Neurosci. 9, 1-17.
2. Alonso M., Vianna M. R., Depino A. M., et al,. (2002) BDNF-triggered events in the rat hippocampus are required for both short- and long-term memory formation. Hippocampus 12, 551-560.
3. Antion M. D., Hou L., Wong H., Hoeffer C. A., and, Klann E., (2008a) mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice. Mol. Cell. Biol. 28, 2996-3007.
4. Antion M. D., Merhav M., Hoeffer C. A., Reis G., Kozma S. C., Thomas G., Schuman E. M., Rosenblum K., and, Klann E., (2008b) Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity. Learn Mem 15, 29-38.
5. Autry A. E., Adachi M., Nosyreva E., Na E. S., Los M. F., Cheng P. F., Kavalali E. T., and, Monteggia L. M., (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 91-95.
6. Banko J. L., Hou L., Poulin F., Sonenberg N., and, Klann E., (2006) Regulation of eukaryotic initiation factor 4E by converging signaling pathways during metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 26, 2167-2173.
7. Barch D. M., and, Ceaser A., (2012) Cognition in schizophrenia: core psychological and neural mechanisms. Trends Cogn Sci 16, 27-34.
8. Bekinschtein P., Katche C., Slipczuk L. N., Igaz L. M., Cammarota M., Izquierdo I., and, Medina J. H., (2007) mTOR signaling in the hippocampus is necessary for memory formation. Neurobiol. Learn. Mem. 87, 303-307.
9. Beretta L., Gingras A. C., Svitkin Y. V., Hall M. N., and, Sonenberg N., (1996) Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15, 658-664.
10. Bock H. H., Jossin Y., Liu P., Forster E., May P., Goffinet A. M., and, Herz J., (2003) Phosphatidylinositol 3-kinase interacts with the adaptor protein Dab1 in response to Reelin signaling and is required for normal cortical lamination. J. Biol. Chem. 278, 38772-38779.
11. Bradshaw N. J., and, Porteous D. J., (2012) DISC1-binding proteins in neural development, signalling and schizophrenia. Neuropharmacology 62, 1230-1241.
12. Burnett P. E., Barrow R. K., Cohen N. A., Snyder S. H., and, Sabatini D. M., (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl Acad. Sci. USA 95, 1432-1437.
13. van den Buuse M., (2010) Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr. Bull. 36, 246-270.
14. van den Buuse M., Halley P., Hill R., Labots M., and, Martin S., (2012) Altered N-methyl-D-aspartate receptor function in reelin heterozygous mice: male-female differences and comparison with dopaminergic activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 37, 237-246.
15. Cammalleri M., Lutjens R., Berton F., King A. R., Simpson C., Francesconi W., and, Sanna P. P., (2003) Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc. Natl Acad. Sci. USA 100, 14368-14373.
16. Campbell D. S., and, Holt C. E., (2001) Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation. Neuron 32, 1013-1026.
17. Catts V. S., Fung S. J., Long L. E., et al,. (2013) Rethinking schizophrenia in the context of normal neurodevelopment. Front Cell Neurosci. 7, 60.
18. Cook S. C., and, Wellman C. L., (2004) Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J. Neurobiol. 60, 236-248.
19. Cracco J. B., Serrano P., Moskowitz S. I., Bergold P. J., and, Sacktor T. C., (2005) Protein synthesis-dependent LTP in isolated dendrites of CA1 pyramidal cells. Hippocampus 15, 551-556.
20. Folsom T. D., and, Fatemi S. H., (2013) The involvement of Reelin in neurodevelopmental disorders. Neuropharmacology 68, 122-135.
21. Gong R., Park C. S., Abbassi N. R., and, Tang S. J., (2006) Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J. Biol. Chem. 281, 18802-18815.
22. Graber T. E., McCamphill P. K., and, Sossin W. S., (2013) A recollection of mTOR signaling in learning and memory. Learn Mem. 20, 518-530.
23. Green A. I., Noordsy D. L., Brunette M. F., and, O'Keefe C., (2008) Substance abuse and schizophrenia: pharmacotherapeutic intervention. J. Subst. Abuse Treat. 34, 61-71.
24. Grider M. H., Park D., Spencer D. M., and, Shine H. D., (2009) Lipid raft-targeted Akt promotes axonal branching and growth cone expansion via mTOR and Rac1, respectively. J. Neurosci. Res. 87, 3033-3042.
25. Hill R. A., Wu Y. W., Gogos A., and, van den Buuse M., (2013) Sex-dependent alterations in BDNF-TrkB signaling in the hippocampus of reelin heterozygous mice: a role for sex steroid hormones. J. Neurochem. 126, 389-399.
26. Holt D. J., Lebron-Milad K., Milad M. R., Rauch S. L., Pitman R. K., Orr S. P., Cassidy B. S., Walsh J. P., and, Goff D. C., (2009) Extinction memory is impaired in schizophrenia. Biol. Psychiatry 65, 455-463.
27. Hou L., and, Klann E., (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 24, 6352-6361.
28. Huang E. P., (1998) Synaptic plasticity: going through phases with LTP. Curr. Biol. 8, R350-R352.
29. Huang W., Zhu P. J., Zhang S., Zhou H., Stoica L., Galiano M., Krnjevic K., Roman G., and, Costa-Mattioli M., (2013) mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat. Neurosci. 16, 441-448.
30. Humphrey S. J., Yang G., Yang P., Fazakerley D. J., Stockli J., Yang J. Y., and, James D. E., (2013) Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2. Cell Metab. 17, 1009-1020.
31. Iafrati J., Orejarena M. J., Lassalle O., Bouamrane L., and, Chavis P., (2013) Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway. Mol. Psychiatry. 19, 417-426.
32. Inamura N., Nawa H., and, Takei N., (2005) Enhancement of translation elongation in neurons by brain-derived neurotrophic factor: implications for mammalian target of rapamycin signaling. J. Neurochem. 95, 1438-1445.
33. Issa G., Wilson C., Terry A. V., Jr, and, Pillai A., (2010) An inverse relationship between cortisol and BDNF levels in schizophrenia: data from human postmortem and animal studies. Neurobiol. Dis. 39, 327-333.
34. Jaaro-Peled H., (2009) Gene models of schizophrenia: DISC1 mouse models. Prog. Brain Res. 179, 75-86.
35. Jacinto E., Facchinetti V., Liu D., Soto N., Wei S., Jung S. Y., Huang Q., Qin J., and, Su B., (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125-137.
36. Jan Y. N., and, Jan L. Y., (2003) The control of dendrite development. Neuron 40, 229-242.
37. Jaworski J., Spangler S., Seeburg D. P., Hoogenraad C. C., and, Sheng M., (2005) Control of dendritic arborization by the phosphoinositide-3'-kinase-Akt- mammalian target of rapamycin pathway. J. Neurosci. 25, 11300-11312.
38. Jefferies H. B., Fumagalli S., Dennis P. B., Reinhard C., Pearson R. B., and, Thomas G., (1997) Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k. EMBO J. 16, 3693-3704.
39. Jossin Y., and, Goffinet A. M., (2007) Reelin signals through phosphatidylinositol 3-kinase and Akt to control cortical development and through mTor to regulate dendritic growth. Mol. Cell. Biol. 27, 7113-7124.
40. Kauderer B. S., and, Kandel E. R., (2000) Capture of a protein synthesis-dependent component of long-term depression. Proc. Natl Acad. Sci. USA 97, 13342-13347.
41. Kim D. H., Sarbassov D. D., Ali S. M., Latek R. R., Guntur K. V., Erdjument-Bromage H., Tempst P., and, Sabatini D. M., (2003) GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol. Cell 11, 895-904.
42. Kumar V., Zhang M. X., Swank M. W., Kunz J., and, Wu G. Y., (2005) Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. J. Neurosci. 25, 11288-11299.
43. Leal G., Comprido D., and, Duarte C. B., (2013) BDNF-induced local protein synthesis and synaptic plasticity. Neuropharmacology. 76, 639-656.
44. LeDoux J. E., (2000) Emotion circuits in the brain. Annu. Rev. Neurosci. 23, 155-184.
45. Liu Y., Wong T. P., Aarts M., et al,. (2007) NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 27, 2846-2857.
46. Ma L., Chen Z., Erdjument-Bromage H., Tempst P., and, Pandolfi P. P., (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193.
47. Malenka R. C., (1994) Synaptic plasticity in the hippocampus: LTP and LTD. Cell 78, 535-538.
48. Marsman A., van den Heuvel M. P., Klomp D. W. J., Kahn R. S., Luijten P. R., and, Hulshoff Pol H. E., (2013) Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr. Bull. 39, 120-129.
49. Martin K. C., (2004) Local protein synthesis during axon guidance and synaptic plasticity. Curr. Opin. Neurobiol. 14, 305-310.
50. Martin S. J., Grimwood P. D., and, Morris R. G., (2000) Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 23, 649-711.
51. McGrath J. J., Féron F. P., Burne T. H., Mackay-Sim A., and, Eyles D. W., (2003) The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann. Med. 35, 86-93.
52. Meffre J., Chaumont-Dubel S., Mannoury la Cour C., et al,. (2012) 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO Mol. Med. 4, 1043-1056.
53. Moghaddam B., and, Javitt D., (2012) From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 37, 4-15.
54. Nestler E. J., (2012) Epigenetics: stress makes its molecular mark. Nature 490, 171-172.
55. Nojima H., Tokunaga C., Eguchi S., et al,. (2003) The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. J. Biol. Chem. 278, 15461-15464.
56. Norman R. M. G., Malla A. K., McLean T. S., McIntosh E. M., Neufeld R. W. J., Voruganti L. P., and, Cortese L., (2002) An evaluation of a stress management program for individuals with schizophrenia. Schizophr. Res. 58, 293-303.
57. Oshiro N., Yoshino K.-I., Hidayat S., Tokunaga C., Hara K., Eguchi S., Avruch J., and, Yonezawa K., (2004) Dissociation of raptor from mTOR is a mechanism of rapamycin-induced inhibition of mTOR function. Genes Cells 9, 359-366.
58. Owen M. J., O'Donovan M. C., Thapar A., and, Craddock N., (2011) Neurodevelopmental hypothesis of schizophrenia. Br. J. Psychiatry 198, 173-175.
59. Parsons R. G., Gafford G. M., and, Helmstetter F. J., (2006) Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons. J. Neurosci. 26, 12977-12983.
60. Pearce L. R., Huang X., Boudeau J., et al,. (2007) Identification of Protor as a novel Rictor-binding component of mTOR complex-2. Biochem. J. 405, 513-522.
61. Pillai A., and, Mahadik S. P., (2008) Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia. Schizophr. Res. 100, 325-333.
62. Piper M., Anderson R., Dwivedy A., Weinl C., van Horck F., Leung K. M., Cogill E., and, Holt C., (2006) Signaling mechanisms underlying Slit2-induced collapse of Xenopus retinal growth cones. Neuron 49, 215-228.
63. Polman J. A., Hunter R. G., Speksnijder N., van den Oever J. M., Korobko O. B., McEwen B. S., de Kloet E. R., and, Datson N. A., (2012) Glucocorticoids modulate the mTOR pathway in the hippocampus: differential effects depending on stress history. Endocrinology 153, 4317-4327.
64. Proud C. G., (2009) mTORC1 signalling and mRNA translation. Biochem. Soc. Trans. 37, 227-231.
65. Roberts R. C., (2007) Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings. Schizophr. Bull. 33, 11-15.
66. Rogers J. T., Zhao L., Trotter J. H., et al,. (2013) Reelin supplementation recovers sensorimotor gating, synaptic plasticity and associative learning deficits in the heterozygous reeler mouse. J. Psychopharmacol. 27, 386-395.
67. Rossé G., and, Schaffhauser H., (2010) 5-HT6 receptor antagonists as potential therapeutics for cognitive impairment. Curr. Top. Med. Chem. 10, 207-221.
68. Sarbassov D. D., Ali S. M., Kim D. H., Guertin D. A., Latek R. R., Erdjument-Bromage H., Tempst P., and, Sabatini D. M., (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302.
69. Sarbassov D. D., Ali S. M., Sengupta S., Sheen J. H., Hsu P. P., Bagley A. F., Markhard A. L., and, Sabatini D. M., (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159-168.
70. Savonenko A. V., Melnikova T., Laird F. M., Stewart K.-A., Price D. L., and, Wong P. C., (2008) Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc. Natl Acad. Sci. USA 105, 5585-5590.
71. Schalm S. S., and, Blenis J., (2002) Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12, 632-639.
72. Schratt G. M., Nigh E. A., Chen W. G., Hu L., and, Greenberg M. E., (2004) BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J. Neurosci. 24, 7366-7377.
73. Sehgal S. N., (1995) Rapamune (Sirolimus, Rapamycin): an Overview and Mechanism of Action. Ther. Drug Monit. 17, 660-665.
74. Siuta M. A., Robertson S. D., Kocalis H., et al,. (2010) Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol. 8, e1000393.
75. Slipczuk L., Bekinschtein P., Katche C., Cammarota M., Izquierdo I., and, Medina J. H., (2009) BDNF activates mTOR to regulate GluR1 expression required for memory formation. PLoS ONE 4, e6007.
76. Stoica L., Zhu P. J., Huang W., Zhou H., Kozma S. C., and, Costa-Mattioli M., (2011) Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc. Natl Acad. Sci. USA 108, 3791-3796.
77. Suri D., and, Vaidya V. A., (2013) Glucocorticoid regulation of brain-derived neurotrophic factor: relevance to hippocampal structural and functional plasticity. Neuroscience 239, 196-213.
78. Swiech L., Perycz M., Malik A., and, Jaworski J., (2008) Role of mTOR in physiology and pathology of the nervous system. Biochim. Biophys. Acta 1784, 116-132.
79. Takahashi T., Hara K., Inoue H., Kawa Y., Tokunaga C., Hidayat S., Yoshino K., Kuroda Y., and, Yonezawa K., (2000) Carboxyl-terminal region conserved among phosphoinositide-kinase-related kinases is indispensable for mTOR function in vivo and in vitro. Genes Cells 5, 765-775.
80. Tamura Y., Kunugi H., Ohashi J., and, Hohjoh H., (2007) Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol. Psychiatry 12, 593-600.
81. Tang S. J., Reis G., Kang H., Gingras A. C., Sonenberg N., and, Schuman E. M., (2002) A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl Acad. Sci. USA 99, 467-472.
82. Tavazoie S. F., Alvarez V. A., Ridenour D. A., Kwiatkowski D. J., and, Sabatini B. L., (2005) Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. 8, 1727-1734.
83. Tee A. R., Manning B. D., Roux P. P., Cantley L. C., and, Blenis J., (2003) Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 1259-1268.
84. Thomanetz V., Angliker N., Cloetta D., Lustenberger R. M., Schweighauser M., Oliveri F., Suzuki N., and, Ruegg M. A., (2013) Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology. J. Cell Biol. 201, 293-308.
85. Tuominen H. J., Tiihonen J., and, Wahlbeck K., (2005) Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis. Schizophr. Res. 72, 225-234.
86. Urbanska M., Gozdz A., Swiech L. J., and, Jaworski J., (2012) Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons. J. Biol. Chem. 287, 30240-30256.
87. Vander Haar E., Lee S. I., Bandhakavi S., Griffin T. J., and, Kim D. H., (2007) Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat. Cell Biol. 9, 316-323.
88. Vickers C. A., Dickson K. S., and, Wyllie D. J., (2005) Induction and maintenance of late-phase long-term potentiation in isolated dendrites of rat hippocampal CA1 pyramidal neurones. J. Physiol. 568, 803-813.
89. Wang L., Harris T. E., and, Lawrence J. C., Jr, (2008) Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation. J. Biol. Chem. 283, 15619-15627.
90. Watanabe Y., Gould E., and, McEwen B. S., (1992) Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res. 588, 341-345.
91. Weiner I., (2003) The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 169, 257-297.
92. Weston M. C., Chen H., and, Swann J. W., (2012) Multiple roles for mammalian target of rapamycin signaling in both glutamatergic and GABAergic synaptic transmission. J. Neurosci. 32, 11441-11452.
93. Wu Y. C., Hill R. A., Klug M., and, van den Buuse M., (2012) Sex-specific and region-specific changes in BDNF-TrkB signalling in the hippocampus of 5-HT1A receptor and BDNF single and double mutant mice. Brain Res. 1452, 10-17.
94. Yang Q., Inoki K., Ikenoue T., and, Guan K. L., (2006) Identification of Sin1 as an essential TORC2 component required for complex formation and kinase activity. Genes Dev. 20, 2820-2832.
95. Zhang Y., Gao X., Saucedo L. J., Ru B., Edgar B. A., and, Pan D., (2003) Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5, 578-581.
96. Zhang J. P., Lencz T., Geisler S., DeRosse P., Bromet E. J., and, Malhotra A. K., (2013) Genetic variation in BDNF is associated with antipsychotic treatment resistance in patients with schizophrenia. Schizophr. Res. 146, 285-288.
97. Zho W. M., You J. L., Huang C. C., and, Hsu K. S., (2002) The group I metabotropic glutamate receptor agonist (S)-3,5-dihydroxyphenylglycine induces a novel form of depotentiation in the CA1 region of the hippocampus. J. Neurosci. 22, 8838-8849.
98. Zhou M., Li W., Huang S., et al,. (2013) mTOR Inhibition ameliorates cognitive and affective deficits caused by Disc1 knockdown in adult-born dentate granule neurons. Neuron 77, 647-654.
99. Ziv N. E., and, Smith S. J., (1996) Evidence for a Role of Dendritic Filopodia in Synaptogenesis and Spine Formation. Neuron 17, 91-102.